The online version of this article (https://doi.org/10.1007/s00125-019-4854-9) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The phytoestrogen enterolactone is a gut microbiota-derived metabolite of plant lignans with suggested beneficial properties for health. In the current study, we investigated the association between pre-diagnostic plasma enterolactone concentrations and mortality among individuals diagnosed with type 2 diabetes.
In a population of people diagnosed with diabetes, nested within the Danish Diet, Cancer and Health cohort, we conducted a case-cohort study including a random sample of n = 450 cases (deceased) and a randomly selected subcohort of n = 850 (in total n = 617 deaths). Information on diagnosis, vital status and cause of death was obtained from Danish registers. Cox proportional hazard models with special weighting were applied to assess all-cause and cause-specific mortality.
The median enterolactone concentration of the current population was low, 10.9 nmol/l (5th percentile to 95th percentile: 1.3–59.6), compared with previously reported concentrations from the Diet, Cancer and Health cohort. Pre-diagnostic enterolactone concentrations were associated with lower all-cause mortality when assessed linearly per doubling in concentration (log2) (HR 0.91 [95% CI 0.85, 0.96]) and according to quartiles (HR 0.63 [95% CI 0.48, 0.84]) for the highest quartile of enterolactone compared with the lowest quartile. For cause-specific mortality, only death from diabetes (registered as underlying cause of death) reached statistical significance.
Based on this large cohort of people with diabetes with detailed and complete baseline and follow-up information, pre-diagnostic enterolactone concentrations were inversely associated with mortality. To our knowledge, this is the first study on enterolactone and type 2 diabetes mortality. Our findings call for further exploration of enterolactone in type 2 diabetes management.
Silva FM, Kramer CK, de Almeida JC, Steemburgo T, Gross JL, Azevedo MJ (2013) Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev 71(12):790–801. https://doi.org/10.1111/nure.12076 CrossRefPubMed
Jonsson K, Andersson R, Bach Knudsen KE et al (2018) Rye and health - where do we stand and where do we go? Trends Food Sci Technol 79:78–87. https://doi.org/10.1016/j.tifs.2018.06.018 CrossRef
Bolvig AK, Norskov NP, Hedemann MS, Foldager L, McCarthy-Sinclair B, Marco ML et al (2017) Effect of antibiotics and diet on enterolactone concentration and metabolome studied by targeted and nontargeted LC-MS metabolomics. J Proteome Res 16(6):2135–2150. https://doi.org/10.1021/acs.jproteome.6b00942 CrossRefPubMed
Pan A, Sun J, Chen Y et al (2007) Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One 2(11):e1148. https://doi.org/10.1371/journal.pone.0001148 CrossRefPubMedPubMedCentral
Tjonneland A, Olsen A, Boll K et al (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35(4):432–441. https://doi.org/10.1080/14034940601047986 CrossRefPubMed
Norskov NP, Kyro C, Olsen A, Tjonneland A, Bach Knudsen KE (2016) High-throughput LC-MS/MS method for direct quantification of glucuronidated, sulfated, and free enterolactone in human plasma. J Proteome Res 15(3):1051–1058. https://doi.org/10.1021/acs.jproteome.5b01117 CrossRefPubMed
World Health Organization (2009) Global health risks. Mortality and burden of disease attributable to selected major risks. World Health Organization, Geneva, pp 9–12
Barlow WE, Ichikawa L, Rosner D, Izumi S (1999) Analysis of case-cohort designs. J Clin Epidemiol 52(12):1165–1172. https://doi.org/10.1016/S0895-4356(99)00102-X CrossRefPubMed
Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18(6):805–835. https://doi.org/10.1097/EDE.0b013e3181577511 CrossRefPubMed
Clavel T, Lippman R, Gavini F, Dore J, Blaut M (2007) C lostridium saccharogumia sp. nov. and Lactonifactor longoviformis gen. nov., sp. nov., two novel human faecal bacteria involved in the conversion of the dietary phytoestrogen secoisolariciresinol diglucoside. Syst Appl Microbiol 30(1):16–26. https://doi.org/10.1016/j.syapm.2006.02.003 CrossRefPubMed
Kyro C, Hansen L, Frederiksen K et al (2017) Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - the Danish Diet, Cancer and Health cohort. Clin Nutr 37(6 Pt A):2217–2225. https://doi.org/10.1016/j.clnu.2017.10.023 CrossRefPubMed
Larsen N, Vogensen FK, van den Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5(2):e9085. https://doi.org/10.1371/journal.pone.0009085 CrossRefPubMedPubMedCentral
Preston SH, Stokes A (2014) Obesity paradox: conditioning on disease enhances biases in estimating the mortality risks of obesity. Epidemiology 25(3):454–461. https://doi.org/10.1097/EDE.0000000000000075 CrossRefPubMedPubMedCentral
Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L (2019) Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 393(10170):434–445. https://doi.org/10.1016/S0140-6736(18)31809-9 CrossRefPubMedPubMedCentral
Ley SH, Hamdy O, Mohan V, Hu FB (2014) Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 383(9933):1999–2007. https://doi.org/10.1016/S0140-6736(14)60613-9 CrossRefPubMedPubMedCentral
- Pre-diagnostic plasma enterolactone concentrations are associated with lower mortality among individuals with type 2 diabetes: a case-cohort study in the Danish Diet, Cancer and Health cohort
Anne K. Eriksen
Natalja P. Nørskov
Knud-Erik Bach Knudsen
- Springer Berlin Heidelberg
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II